BTG and HealthLoop Collaborate on IO Loop(TM), an Exclusive Service to Connect Patients and Interventional Oncologists Throughout Treatment
Friday, May 19, 2017
LONDON, May 19, 2017 /PRNewswire/ --
Data from a pilot study using IO Loop(TM) with TheraSphere(R) (a 90Y transarterial
radioembolisation therapy) will be presented at the World Conference on Interventional
BTG plc (LSE: BTG), a global specialist healthcare company, and HealthLoop, a
cloud-based platform that automates follow-up patient care, announced today their
collaboration on IO Loop(TM). This is an exclusive service from BTG that gives access to a
turn-key digital support platform powered by Healthloop. IO Loop(TM) enables patients and
their physicians to stay connected, providing improved pre-procedural patient instructions
and ongoing follow-up care outside of the acute care setting. This service also provides
the care team with patient-reported outcomes that help physicians meet the new reporting
requirements of Medicare Access and CHIP Authorisation Act (MACRA).
Patients are the most underleveraged resource in the achievement of better health
outcomes. IO Loop(TM) empowers patients by connecting them with their physician via a
digital support platform, and fully engages them in their treatment journey. Online
engagement before, during and after treatment has the potential to reduce physician burden,
delivering the right information at the right time. The IO Loop(TM) service helps
patients prepare for their treatment, track and report any symptoms, review key treatment
information at the appropriate time, and provides a personalised follow-up care plan with
appropriate advice. This support results in a better overall patient experience.
Lisa Hayden, Vice President, Global Reimbursement at BTG commented: "We know that
patients who are involved in their treatment journey have the best chance of better
outcomes, and at BTG we are committed to providing solutions to achieve this. Through IO
Loop(TM), the first service of its kind in interventional oncology, automated collection
of patient information, improved patient outcomes, and potentially enhanced patient
experiences can have unique benefits for healthcare providers and help them to meet the
reporting requirements of MACRA."
Todd Johnson, HealthLoop CEO said of the partnership: "At HealthLoop our mission is to
keep physicians and patients connected via our proven technology-enabled engagement
platform. By partnering with BTG on this important initiative we believe that we can
empower patients and offer the best experience both for them and their healthcare
The collaboration leverages BTG's leadership in interventional oncology with
HealthLoop's digital expertise in patient-centric solutions, offering a unique service
that has the potential to differentiate and simplify interventional oncology practice.
Karen Grace, Clinical Nurse Coordinator, Interventional Oncology at Northwestern
Memorial Hospital, Chicago commented: "At Northwestern we have experienced the benefits of
the IO Loop(TM) service first hand. Having ongoing access to the patient's performance has
enabled timely intervention, which in turn has minimised complications and reduced the
likelihood of re-admission. This not only improves the quality of life of our patients but
also enables us, as healthcare providers, to deliver a higher standard of care."
Data showing the benefits of this technology with TheraSphere(R) in interventional
oncology will be presented next month at the World Conference on Interventional Oncology
(WCIO) in Boston, U.S., 8-11 June 2017.
About BTG Interventional Oncology
BTG Interventional Oncology is transforming the way cancer is treated with
wide-ranging solutions consisting of minimally-invasive, highly targeted therapies that
can be personalized to each patient's needs. Our products are used to treat or provide
symptomatic relief for people with cancer and benign tumors. To learn more about BTG
Interventional Oncology, please visit: https://www.btg-im.com.
HealthLoop engages patients at home before their admission and for weeks and months
after discharge to continuously guide, educate, and assess the status of their recovery.
By automatically sending notifications to patients, HealthLoop remotely monitors patients
and identifies those that need help, allowing clinical teams to proactively intervene
before costs and complications escalate. Developed as an enterprise solution to support
all clinical specialties, HealthLoop's content and analytics are deeply integrated into
care management workflows. HealthLoop facilitates over 500,000 patient interactions every
month. To learn more, please visit: http://www.healthloop.com.
TheraSphere(R) 90Y glass microspheres are specifically engineered to carry far greater
power than any other 90Y liver-directed cancer therapy, delivering high doses of radiation
to liver tumors while sparing normal tissue. The result is a powerful, targeted and
well-tolerated therapy that may lead to patients becoming eligible for curative therapies.
In the EU, Singapore, South Korea and Canada, TheraSphere(R) is approved for the
treatment of hepatic neoplasia. In the US, TheraSphere(R) is approved under a Humanitarian
Device Exemption (HDE) for use in radiation treatment or as a neoadjuvant to surgery or
transplantation in patients with unresectable hepatocellular carcinoma (HCC) who can have
placement of appropriately positioned hepatic arterial catheters. The device is also
indicated for HCC patients with partial or branch portal vein thrombosis/occlusion, when
clinical evaluation warrants the treatment. The effectiveness of this device for this use
has not been demonstrated.
For full instructions for use and important safety information, please visit
SOURCE BTG Plc
||IBM VP & Chief Health Informatics Officer Dr. Anil K. Jain Appointed to the Health Information Technology Advisory Committee | Jun 23, 2017
||The Global Syringes Market Forecast 2017-2027 | Jun 23, 2017
||Former Arrow Electronics COO Joins ENAVATE Board of Directors | Jun 23, 2017
||IBM Research and Cornell University to Use Genetic Sequencing and Big Data Analytics to Help Keep Global Milk Supply Safe | Jun 23, 2017
||Research and Markets - BFSI Security Market Forecasts to 2023 - Key Players are IBM, Cisco, Symantec, McAfee, Oracle, Herjavec Group, Stromshield, Dell Security, Gemalto NV, Accenture & Trend Micro | Jun 23, 2017
||Tencent YouTu Lab Launched YouTu Skyeye for People Search | Jun 23, 2017
||Panopto Again Named One of Washington's 100 Best Places to Work | Jun 23, 2017
||ThetaRay Chosen for Three Exclusive Cyber Week 2017 Panels | Jun 23, 2017
||B-Stock Solutions Named a Supply & Demand Chain Executive SDCE 100 For Outstanding Reverse Supply Chain Project | Jun 23, 2017
||Nintex Named for Third Year in a Row as one of Washington's 100 Best Companies to Work For, According to Seattle Business Magazine | Jun 23, 2017